Healthcare Professionals
Important Safety Information
Healthcare Professionals
Sign Up for Support
Two women laughing while looking at a phone
Two women laughing while looking at a phone

Life is more
breathtaking
than lung cancer

RYBREVANT FASPRO™ and
RYBREVANT® are 2nd treatments
for people with EGFR+ NSCLC with exon
20 insertion mutations.

Actor portrayals.

About NSCLC

Learn about NSCLC, EGFR mutations, and what this means for you.

What to expect with RYBREVANT FASPRO™–based or RYBREVANT®-based treatments

Get more information about the treatment, possible side effects, and how to prepare.

Savings & support

Tips and resources, including financial support, to help you.

EGFR+, mutated epidermal growth factor receptor; NSCLC, non–small cell lung cancer.
Man and woman embracing each other in front of a fountain
Man and woman embracing each other in front of a fountain

Facing NSCLC together

Facing lung cancer comes with many challenges, but you're not alone.

There are many groups that can help support people living with lung cancer as well as their loved ones.

Elderly woman smiling happily outdoors
Elderly woman smiling happily outdoors

Savings & support

Once prescribed RYBREVANT FASPRO™ or RYBREVANT®, connect with a Care Navigator for your support needs.

The support and resources provided by RYBREVANT withMe are not intended to provide medical advice, replace a treatment plan you receive from your doctor or nurse, or serve as a reason for you to start or stay on treatment.